Luisa Imberti Selected Research

COVID-19 related pediatric multisystem inflammatory disease

1/2022

Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luisa Imberti Research Topics

Disease

26	COVID-19 12/2023 - 01/2020
18	Multiple Sclerosis 01/2023 - 09/2007
10	Infections 11/2023 - 03/2002
8	Pneumonia (Pneumonitis) 11/2023 - 09/2020
7	Progressive Multifocal Leukoencephalopathy 01/2022 - 09/2013
6	HIV Infections (HIV Infection) 11/2023 - 09/2005
6	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018 - 04/2004
5	Virus Diseases (Viral Diseases) 11/2023 - 06/2011
5	Neoplasms (Cancer) 06/2023 - 01/2009
4	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2018 - 11/2005
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2005
3	Relapsing-Remitting Multiple Sclerosis 01/2020 - 02/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2018 - 06/2011
3	Lymphoma (Lymphomas) 12/2016 - 09/2005
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2016 - 10/2002
3	Melanoma (Melanoma, Malignant) 09/2010 - 01/2009
2	Opportunistic Infections (Opportunistic Infection) 11/2023 - 10/2017
2	Disease Progression 01/2021 - 07/2017
2	Immune Reconstitution Inflammatory Syndrome 01/2019 - 07/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2016 - 09/2005
2	Hepatitis 04/2007 - 01/2005
1	Cytomegalovirus Infections (Inclusion Disease) 11/2023
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 11/2023
1	Colorectal Neoplasms (Colorectal Cancer) 06/2023
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2023
1	Prostatic Neoplasms (Prostate Cancer) 03/2023
1	Mycoses (Diseases, Fungus) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Nervous System Diseases (Neurological Disorders) 07/2022
1	Breakthrough Infections 06/2022
1	Gastritis 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Convalescence 01/2022
1	COVID-19 related pediatric multisystem inflammatory disease 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Thymoma (Thymic Carcinoma) 11/2021
1	Inflammation (Inflammations) 01/2021

Drug/Important Bio-Agent (IBA)

13	AutoantibodiesIBA 11/2023 - 10/2020
12	AntibodiesIBA 11/2023 - 09/2007
11	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 10/2002
9	InterferonsIBA 12/2023 - 09/2010
8	Interferon Type IIBA 12/2023 - 03/2008
7	Messenger RNA (mRNA)IBA 12/2023 - 03/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
7	Natalizumab (Tysabri)FDA Link 01/2020 - 01/2012
6	AntigensIBA 07/2022 - 01/2009
6	Peptides (Polypeptides)IBA 01/2022 - 01/2009
5	VaccinesIBA 06/2022 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2011
5	Interferon-betaIBA 01/2015 - 06/2008
4	CytokinesIBA 03/2023 - 03/2011
3	EpitopesIBA 12/2023 - 03/2009
3	mRNA VaccinesIBA 12/2023 - 11/2021
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2007
3	Adenosine DeaminaseIBA 01/2018 - 11/2005
3	Staphylococcal Protein A (Protein A)IBA 01/2014 - 11/2008
3	MART-1 AntigenIBA 09/2010 - 01/2009
2	Complement System Proteins (Complement)IBA 03/2023 - 01/2015
2	Alemtuzumab (Campath)FDA Link 01/2023 - 01/2019
2	Immunoglobulin M (IgM)IBA 07/2022 - 01/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2022
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 12/2014
2	Immunoglobulin G (IgG)IBA 01/2022 - 10/2020
2	Chemokine CCL5IBA 01/2020 - 03/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2018 - 01/2015
2	Monoclonal AntibodiesIBA 10/2017 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 03/2011
2	pegademase bovine (pegADA)FDA Link 12/2010 - 11/2005
2	Dacarbazine (DIC)FDA LinkGeneric 09/2010 - 01/2009
2	Cancer VaccinesIBA 03/2009 - 01/2009
1	ProteomeIBA 12/2023
1	Anti-Idiotypic AntibodiesIBA 11/2023
1	Immune Checkpoint ProteinsIBA 06/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2023
1	AntioxidantsIBA 03/2023
1	CarbohydratesIBA 07/2022
1	Polysaccharides (Glycans)IBA 07/2022
1	COVID-19 VaccinesIBA 06/2022
1	Insulin (Novolin)FDA Link 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	HLA-B Antigens (HLA-B)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	AutoantigensIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	Immunoglobulin E (IgE)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021

Therapy/Procedure

22	Therapeutics 01/2023 - 09/2005
6	Transplantation 10/2015 - 04/2004
5	Stem Cell Transplantation 11/2018 - 10/2002
4	Hematopoietic Stem Cell Transplantation 01/2014 - 09/2005
3	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 01/2003
3	Drug Therapy (Chemotherapy) 12/2016 - 09/2005